Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Our lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions.
| Website | https://www.sudobio.com/ |
| Employees | 30 (19 on RocketReach) |
| Address | 10401 N Meridian St 225, Carmel, Indiana 46290, US |
| Industry | Biotechnology Research |
| Keywords | Biopharmaceutical, Biotechnology, New Drug Discovery, Drug Development, Pharmaceutical Research, Drug Discovery Platform, Precision Medicine, Clinical Trials, Small Molecule Drugs, Target Discovery, Pharmaceutical Innovation, Therapeutic Proteins, Biologics, Medicinal Chemistry, Immunology, Translational Medicine, Protein Engineering, Oncology, Rare Diseases |
| Competitors | Amgen, ADM, Novozymes, Codexis, Inc., Editas Medicine, LanzaTech, Caribou Biosciences, Geno, Perfect Day, Zymergen, Inc. +40 more (view full list) |
Looking for a particular Sudo Biosciences employee's phone or email?
Sudo Biosciences Questions
Scott Byrd is the CEO of Sudo Biosciences.
19 people are employed at Sudo Biosciences.
Sudo Biosciences is based in Carmel, Indiana.
Top Sudo Biosciences Employees
-
Scott Byrd
Chief Executive Officer at Sudo Biosciences
Zionsville, IN, US35 -
Paul S. Bavier
Chief Legal Officer at Sudo Biosciences
Cambridge, MA, US34 -
Anjali Pandey
SVP, Medicinal Chemistry at Sudo Biosciences
California, United States25+ -
Ian Mills
Chief Medical Officer at Sudo Biosciences
United Kingdom31 -
3
-
Clíona MacSweeney
Head of Translational Medicine at Sudo Biosciences
Cambridge, Cambridgeshire, United Kingdom31 -
Imran Babar
Chief Business and Financial Officer at Sudo Biosciences
Charlotte, NC, US34
Related Companies
G2Crowd Trusted
300K+
Plugin Users
